CLXT - Biotechnology company Calyxt appoints President/CEO
Plant-based biotech Calyxt (CLXT) appointed Michael Carr as President, CEO and board member effective July 27.Carr previously served as vice president of M&A, Strategy, and Innovation at Darling Ingredients Inc., a developer of sustainable natural ingredients and renewable energy. "Michael's operational, financial, and investment experience, paired with his diverse knowledge across industries including health, nutrients, bioenergy and services will be integral as we advance Calyxt's vision built around our cutting-edge plant-based technologies," said Executive Chair Yves Ribeill. Source: Press Release
For further details see:
Biotechnology company Calyxt appoints President/CEO